Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Cochrane

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Heart, Lung & Circulation|September 5, 2017
Transcatheter Pulmonary Valve Implantation Provides Effective TreatmentAndrew Cochrane, Yves d'Udekem, Michael Cheung
Heart Asia|June 22, 2016
Saphenous vein coronary bypass graft aneurysm with fistula to right atrium demonstrated on dynamic-volume 320-slice computed tomographyBrian Ko, Andrew Cochrane, Sujith Seneviratne
ANZ Journal of Surgery|June 18, 2024
Cutting carbon out of surgical care deliveryBen Dunne, Andrew Cochrane, David Fletcher
Emergency Medicine Australasia : EMA|November 18, 2017
Windsock in the heartAnthony Wald, Andrew Cochrane, Gabriel Blecher, et al.
Heart, Lung & Circulation|July 27, 2018
ANZSCTS ASM 2017 - International Perspectives on Contemporary Issues in Cardiothoracic Surgical PracticeAndrew Cochrane, Phillip Antippa, Aubrey Almeida, et al.
Therapeutic Innovation & Regulatory Science|September 7, 2021
Adverse Events in the Digital Age: Finding the Sharpest Tool in the BoxRobert Di Giovanni, Andrew Cochrane, David J Lewis
Paediatric Anaesthesia|May 22, 2004
Delayed rises in serum S100B levels and adverse neurological outcome in infants and children undergoing cardiopulmonary bypassDavid Lardner, Andrew Davidson, Ian McKenzie, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 22, 2006
Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapyHenry Ekert, Christian Brizard, Robert Eyers, et al.
Pharmacoepidemiology and Drug Safety|August 23, 2022
Adverse events in the digital age and where to find themRobert Di Giovanni, Andrew Cochrane, Jeremy Parker, et al.
Heart, Lung & Circulation|September 27, 2016
Reply to Letter to the Editor - The Definition of 'Urgent' in Australia and New Zealand Society of Cardiac and Thoracic Surgeons DatabaseMd Nazmul Karim, Christopher M Reid, Andrew Cochrane, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Heart, Lung & Circulation|September 5, 2017
Transcatheter Pulmonary Valve Implantation Provides Effective TreatmentAndrew Cochrane, Yves d'Udekem, Michael Cheung
Heart Asia|June 22, 2016
Saphenous vein coronary bypass graft aneurysm with fistula to right atrium demonstrated on dynamic-volume 320-slice computed tomographyBrian Ko, Andrew Cochrane, Sujith Seneviratne
ANZ Journal of Surgery|June 18, 2024
Cutting carbon out of surgical care deliveryBen Dunne, Andrew Cochrane, David Fletcher
Emergency Medicine Australasia : EMA|November 18, 2017
Windsock in the heartAnthony Wald, Andrew Cochrane, Gabriel Blecher, et al.
Heart, Lung & Circulation|July 27, 2018
ANZSCTS ASM 2017 - International Perspectives on Contemporary Issues in Cardiothoracic Surgical PracticeAndrew Cochrane, Phillip Antippa, Aubrey Almeida, et al.
Therapeutic Innovation & Regulatory Science|September 7, 2021
Adverse Events in the Digital Age: Finding the Sharpest Tool in the BoxRobert Di Giovanni, Andrew Cochrane, David J Lewis
Paediatric Anaesthesia|May 22, 2004
Delayed rises in serum S100B levels and adverse neurological outcome in infants and children undergoing cardiopulmonary bypassDavid Lardner, Andrew Davidson, Ian McKenzie, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 22, 2006
Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapyHenry Ekert, Christian Brizard, Robert Eyers, et al.
Pharmacoepidemiology and Drug Safety|August 23, 2022
Adverse events in the digital age and where to find themRobert Di Giovanni, Andrew Cochrane, Jeremy Parker, et al.
Heart, Lung & Circulation|September 27, 2016
Reply to Letter to the Editor - The Definition of 'Urgent' in Australia and New Zealand Society of Cardiac and Thoracic Surgeons DatabaseMd Nazmul Karim, Christopher M Reid, Andrew Cochrane, et al.
Pageof 5